Myofibroblastic differentiation in simple peritoneal sclerosis

International Journal of Artificial Organs

Volumn 28, Issue 2, 2005, Pages 135-140

  Del Peso, Gloria ^a,d   Jimenez Heffernan J A ^b,d   Bajo, M A ^a,d   Hevia, C ^a,d   Aguilera, A ^c,d   Castro, M J ^a,d   Sanchez Tomero J A ^c,d   Lopez Cabrera M ^c,d   Selgas, R ^a,d  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Section of Nephrology   (Spain)

Author keywords

Fibrosis; Myofibroblast; Peritoneal dialysis; Uremia

Indexed keywords

BIOPSY; DIALYSIS; ENDOTHELIAL CELLS; PATIENT TREATMENT; UREA;

FIBROSE; MORPHO-LOGICS; MYOFIBROBLASTS; NORMAL CONTROLS; PERITONEAL DIALYSIS; PROGESTERONE RECEPTOR; SIMPLE++; UREMIA; UREMIC PATIENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

PROTEINS;

ALPHA ACTIN; CREATININE; PROGESTERONE RECEPTOR; PROTEIN BCL 2; UREA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION FUNCTION; DIGESTIVE TRACT PARAMETERS; FEMALE; FIBROBLAST; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM; MICROMORPHOLOGY; MYOFIBROBLAST; PERITONEAL BIOPSY; PERITONEUM; PERITONITIS; PROTEIN EXPRESSION; RELIABILITY; SAMPLING; SCLEROSING PERITONITIS; SCLEROSIS; SMOOTH MUSCLE; STATISTICAL SIGNIFICANCE; THICKNESS; ULTRAFILTRATION; UREMIA; VASCULAR DISEASE;

EID: 16844380963     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800209     Document Type: Article

References (25)

1. Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; 20 (suppl 3): S5-96.
2. Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
3. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West B. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999; 277: C1-19.
4. Schürch W, Seemayer TA, Gabbiani G. The myofibroblast. A quarter century after its discovery. Am J Surg Pathol 1998; 22: 141-7.
5. Mateijsen MAM, van der Wal AC, Hendriks PMEM, Zweers MM, Struijk DG, Krediet RT. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-25.
6. Shioshita K, Miyazaki M, Ozono Y, et al. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int 2000; 57: 619-31.
7. Nakazato Y, Yamaji Y, Oshima N, Hayashi M, Saruta T. Calcification and osteopontin localization in the peritoneum of patients on long-term continuous ambulatory peritoneal dialysis therapy. Nephrol Dial Transplant 2002; 17: 1293-303.
8. Bertoli SV, Buzzi L, Ciurlino D. Morphofunctional study of peritoneum in peritoneal dialysis patients. J Nephrol 2003; 16: 373-8.
9. Honda K, Nitta K, Horita S. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory dialysis patients. Adv Perit Dial 2003; 19: 169-75.
10. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-41.
11. Plum J, Hermann S, Fussholler A, et al. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 2001; 78 (suppl): S42-7.
12. Combet S, Ferrier ML, Van Landschoot, et al. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 2001; 12: 2146-57.
13. Jimenez-Heffernan JA, Aguilera A, Azoeira L, et al. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneum and peritoneal dyalisis-induce fibrosis. Virchows Arch 2004; 444: 247-56.
14. Bongiovanni M, Viberti L, Pecchioni C, et al. Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells. J Pathol 2002; 198: 252-7.
15. Gabbiani G, Ryan GB, Maine G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27: 549-50.
16. Yoshio Y, Miyazaki M, Abe K, et al. TNP-470, an angiogenesis inhibitor, suppresses the progresión of peritoneal fibrosis in mouse experimental model. Kidney Int 2004; 66: 1677-85.
17. Okada H, Inoue T, Kanno Y, et al. Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int 2003; 64: 1722-32.
18. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63: 1530-9.
19. Yañez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. New Engl J Med 2003; 348: 403-13.
20. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implication in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-75.
21. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-50.
22. Dunsmore SE, Shapiro SD. The bone marrow leaves its scar: New concepts in pulmonary fibrosis. J Clin Invest 2004; 113: 180-2.
23. Garantziotis S, Steele MP, Schwartz. Pulmonary fibrosis: Thinking outside the lung. J Clin Invest 2004; 114: 319-21.
24. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 170: 380-9.
25. Forbes SJ, Russo FP, Rey V, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126: 955-63.